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protein snap-frozen and stored at -80˚C. -COP-GFP [47] (kindly provided by Theresa Ward, LSHTM, London and Jennifer Lippincott-Schwartz, NIH, Bethesda) was amplified by PCR and subcloned into pLVX-Puro (Clontech) using EcoRI-XhoI sites generate a lentivirus from which -COP-GFP was stably expressed in NRK cells. Plasmid encoding GFP-tagged wild-type ARF1 was kindly provided by Jennifer Lippincott-Schwartz (NIH, Bethesda).
Retroviral Infection of Mammalian Cells
Retroviral infection was carried out as reported previously [48] . Packaging cell line Plat-A (Prof. Toshio Kitamura, University of Tokyo) was kept in DMEM containing 1 g/ml puromycin and 10 g/ml blasticidin. Retroviral transfer plasmids were transfected using FuGENE 6 (Roche Biochemicals) into Plat-A cells. After 48 h, conditioned media were filtered through a 0.45 m filter and used as a virus stock. For infection, target cells were cultured with a virus stock diluted into an equal volume of DMEM/10% FCS containing 8 g/ml Polybrene. Stable infectants of HeLa cells were generated by selection in DMEM containing 2 g/ml puromycin. Cells were analysed at 10-14 days after infection.
Fluorescence microscopy
Adherent HeLa or NRK cells were grown on glass coverslips at 37°C and 5% CO 2 in DMEM containing 10% foetal calf serum (FCS). For the enrichment of mitotic NRK cells, 2.5 g/ml aphidicolin was added to the medium for 14-16 h to arrest cells at the G1/S boundary. Cells were washed 5-6 times to remove the residual drug and incubated in fresh medium for 5-7 h to allow progression into mitosis. Unsynchronised HeLa cell were transfected with ARF1-GFP 16-20 h before fixation using Fugene 6 according to the manufacturer's instructions. Cells were fixed in paraformaldehyde (3% in PBS) for 20 min at room temperature, quenched with 10 mM glycine, pH 8.5 in PBS, and permeabilized with 0.1 % Triton X-100 in PBS for 5 min at room temperature. Labelling was performed by sequentially incubating with primary then secondary antibodies diluted in PBS containing 0.5 mg/ml BSA for 20 min at room temperature. Images were acquired using an Olympus BX60 microscope equipped with a coolSNAP EZ CCD camera using Metaview software (Universal Imaging) and processed using Adobe Photoshop CS.
Incubations with Interphase and Mitotic Cytosol
Incubations of rat liver Golgi with interphase or mitotic cytosol prepared from HeLa S3 cells was carried out according to [44] . Briefly, 10 µg Golgi membranes were incubated with 40 µl interphase or mitotic cytosol (at 9 mg/ml in buffer A: 20 mM -glycerophosphate, 15 mM EGTA, 10 mM MgOAc, 50 mM KOAc, 2 mM ATP, 1 mM DTT, 0.2 M sucrose) in the presence of an ATP regeneration system (10 mM creatine phosphate, 20 µg/ml creatine kinase) for various times at 30˚C. Membranes were re-isolated by centrifugation through a 0.4 M sucrose cushion. In certain experiments 10 µM staurosporine or 2 µl (20 Units) Calf Intestinal Alkaline Phosphatase (NEB) was included in the incubation. In some experiments the ATP regeneration system was omitted and [ - 32 P]ATP added at 0.5 µCi/µl. In vitro translated 35 S-labelled GBF1 was made using the TnT Coupled Reticulocyte Lysate System (Promega) according to the manufacturer's instructions. 0.5 l of in vitro translated protein was incubated with 20 l of interphase or mitotic cytosol (2 mg/ml in buffer A with ATP regeneration system) for 30 min at 30ºC. 1 g of GSTtagged GBF1 or S-tagged GM130 was bound to 10 l glutathione or protein S-coupled beads and incubated with 20 l of interphase or mitotic cytosol at 2 or 9 mg/ml containing 0.5 µCi/µl [ - 32 P]ATP for 30 min at 30˚C. In some cases parallel incubations were performed by adding 10 µg histone type III-S (Sigma). Inhibitors were added from 100x concentrated stock solutions in A c c e p t e d M a n u s c r i p t Licenced copy. Copying is not permitted, except with prior permission and as allowed by law.
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DMSO while controls contained DMSO vehicle only. Cyclin B-CDK1 was purified from insect cells and added to give 0.4x and 1.0x of added histone kinase activity of mitotic cytosol. Proteins were solubilized in SDS sample buffer and analysed by SDS-PAGE and autoradiography on BioMax MS film (Kodak).
Immunoprecipitation of GBF1 and Far Western blotting
Interphase or mitotic rat liver Golgi membranes were extracted in extraction buffer (20 mM Tris, 50 mM KCl, 5 mM MgCl 2 , 0.5 % Triton X-100) containing protease inhibitors for 1 h on ice prior to clarification by centrifugation. Clarified Golgi membrane extracts or interphase or mitotic HeLa S3 cytosol (containing 0.5% Triton X-100 and protease inhbitors) were incubated with 2 µg mouse anti-GBF1 antibody followed by 20 µl protein G-Sepharose for 2 h at 4˚C. After washing, bound proteins were eluted and analysed by SDS-PAGE and autoradiography, Western blotting or Far Western blotting. In some cases immunprecitates were incubated with 2 µl (20 Units) Calf Intestinal Alkaline Phosphatase (NEB) in 50 mM Tris pH 7.9, 0.1 M NaCl, 10 mM MgCl 2 , 1 mM DTT for 30 min at 37˚C prior to elution. Far Western blotting was performed by transferring proteins to nitrocellulose membrane, blocking the membrane in PBS containing 0.2% Tween-20 and 5% milk powder, followed by incubation with 1 µg/ml GST-tagged Plk1 PBD in PBS containing 0.2% Tween-20 and 2% milk powder for 3 h at room temperature. Bound Plk1 PBD was detected by incubating with anti-GST antibodies followed by HRP-conjugated secondary antibodies and ECL.
Identification of Plk1 Polo Box Domain Binding Proteins
For large scale identification of Golgi Plk1 PBD binding proteins 200 g rat liver Golgi membranes were incubated with 500 l mitotic cytosol (9 mg/ml in buffer A) containing 0.5
Ci/ l [ -32 P]ATP for 30 min at 30ºC. Membranes were reisolated by centrifugation through a 0.4 M sucrose cushion for 10 min at 55,000 rpm in a TLA55 rotor. Membranes were extracted in extraction buffer (20 mM Tris, 50 mM KCl, 5 mM MgCl 2 , 0.5 % Triton X-100) for 1 h on ice, clarified by centrifugation, and incubated with 10 g GST-Plk1 PBD bound to glutathione-Sepharose for 1 h at 4˚C. Beads were washed and bound proteins analysed by SDS-PAGE and autoradiography or Western blotting. Radiolabelled proteins were excised from re-hydrated gel slices and identified using mass spectrometry by the University of Manchester Faculty of Life Sciences Biomolecular Analysis Facility.
Kinase inhibitor treatment of HeLa cells
Treatment with kinase inhibitors was performed on adherent HeLa cells grown in 12 well plates. Cells were arrested in mitosis with 100 ng/ml nocodazole for 22-24 h at 37˚C and treated with the required concentration of kinase inhibitor for an additional 1 h at 37˚C. Cells were harvested, washed in cold PBS and extracted in 100 l extraction buffer containing 20 mMglycerophosphate and protease inhibitors. Samples were analysed by SDS-PAGE and Western blotting.
Fractionation of HeLa cells
HeLa S3 cells were cultured in 250 ml spinner flasks. Mitotic cells were prepared by incubating in 100 ng/ml nocodazole for 22-24 h at 37˚C. In some experiments brefeldin-A was added at 5 g/ml for 10 min prior to harvesting. Cells were harvested by centrifugation, washed in PBS, and after swelling in 0.4 x lysis buffer (1x is 20 mM Hepes pH7.4, 50 mM KCl, 5 mM MgCl 2 , 1 mM DTT, 0.2M sucrose), cells were lysed in 1x lysis buffer containing protease inhbitors by passing through a ball bearing homogenizer (8.02 mm barrel with 8.01 mm ball). Lysates were then cleared by centrifugation 1000 x g for 10 min to generate a post-nuclear supernatant. This was subsequently layered onto lysis buffer containing 0.4 M sucrose and cytosol and membrane fractions were generated by centrifugation at 50,000 rpm for 15 min in a TLS55 rotor. Retrovirally transduced adherent HeLa cells expressing Myc-tagged GBF1 were scraped into PBS, washed as above and homogenized in lysis buffer by passing through a 25G needle. Resulting homogenates were fractionated as above. Quantitation of bands was performed by densitometry using ImageJ software.
GST-GGA3 binding experiments
Interphase or mitotic HeLa S3 cells (25 ml of suspension culture) were incubated without or with 10 µg/ml brefeldin-A for 1 h at 37˚C prior to washing in cold PBS and lysis in 800 µl 50 mM Tris, pH 7.5, 0.1 M NaCl, 5 mM MgCl 2 , 1%Triton X-100 containing protease inhibitors. After clarify by centrifugation, 300 µl extract was incubated with 30 µl glutathione-Sepharose containing 50 µg bound GST or GST-GGA3 VHS-GAT domain for 1 h at 4˚C. After washing the beads, bound ARF was detected by Western blotting. Quantitation of bands was performed by densitometry using ImageJ software.
Fluorescence recovery after photobleaching (FRAP)
NRK cells stably expressing -COP-GFP were grown on MatTek dishes and synchronized at 40% confluence with 2 mM thymidine for 16 h. Cells were washed with PBS and incubated in fresh DMEM for 8 h. FRAP was performed between 10-12 h after the second synchronization. Cells were imaged at 37ºC with the Perkin Elmer UltraVIEW ERS 6FE confocal system attached to a Leica DM I6000 inverted epifluorescence microscope encompassing Yokogawa CSU22 spinning disk technology and a Hamamatsu C9100-50 EM-CCD camera controlled by Volocity 5 (Improvision) acquisition software. Cells were imaged in MEM without phenol red, supplemented with 30 mM HEPES, pH 7.4, 0.5 g l -1 sodium bicarbonate and 10% fetal calf serum using a 63x 1.3 NA Plan-Apochromat objective. Photobleaching of -COP-GFP was performed with a~500 nm diameter circular region. Pre-bleach images were collected for 5 seconds and post-bleach images were collected for 60 seconds using 30% AOTF power and low laser intensity. For -COP-GFP FRAP was performed at a rate of 5 time points per second, and regionof-interest bleaching with 5 iterations of the 488 and 514 nm lasers at 100% AOTF power. Punctae that moved out of focus or moved over 500 nm during the photobleaching series could not be analysed. Fluorescence recovery in the bleached region during the time series was quantified using Volocity 5 (Improvision) FRAP analysis software and exported for analysis to GraphPad Prism 4.02. Recycling kinetics were obtained by curve fitting to a one phase exponential ƒ(t) = A•(1-e-kt) + B, Here, "A" is the mobile fraction, "B" is the fluorescence directly after photobleaching (%), and k is the rate of fluorescence recovery from which t is determined (t = ln(2) / k). Statistical significance was tested using standard deviation and the students' unpaired t-test.
Results

Identification of GBF1 as a mitotic phosphoprotein
To identify novel mitotic Golgi phosphoproteins we used a previously described in vitro assay in which rat liver Golgi membranes are incubated with cytosol from interphase or mitotic HeLa cells [14, 43] . Golgi extracts were then prepared and incubated with immobilized Plk1 polo box A c c e p t e d M a n u s c r i p t Licenced copy. Copying is not permitted, except with prior permission and as allowed by law. 8 domain (PBD) before mass spectrometry identification of bound proteins. The Plk1 PBD is a phosphoserine/threonine binding domain that targets Plk1 to various mitotic substrates [49, 50] . We used binding to the Plk1 PBD to simplify the profile of Golgi phosphoproteins as well as identify new potential Golgi-localised Plk1 binding partners. As shown in Fig 1A ( top) several mitotically phosphorylated Golgi proteins bound to wild-type Plk1 PBD but not a H538A/K540M mutant unable to bind phosphorylated ligands [49] . Amongst the specifically bound proteins were GRASP65, previously identified as a Plk1 PBD ligand [51] , and GM130, which may bind Plk1 PBD indirectly via its association with GRASP65 ( Fig 1A, open arrowheads). A minor phosphoprotein running at 210 kDa was identified as GBF1, the Golgiassociated ARF nucleotide exchange factor ( Fig 1A, filled arrowhead) . The identity of GBF1 as a Plk1 PBD binding protein was confirmed by Western blotting (Fig 1A, bottom) . GBF1 bound to wild-type but not mutant Plk1 PBD, with stronger binding observed under mitotic conditions. These results suggest that GBF1 undergoes mitosis-specific phosphorylation. This was tested by incubating Golgi membranes with cytosol in the presence of [ -32 P]ATP and immunoprecipitating the protein with specific antibodies. As shown in Fig 1B, GBF1 was phosphorylated by mitotic cytosol. Phosphorylation is quantitative, causing a molecular weight shift in the entire pool of cytosolic GBF1 ( Fig 1C) . Interestingly, we also observed a lower level of interphase phosphorylation ( Fig 1B, C) . Far Western blotting confirmed that GBF1 can directly bind to the Plk1 PBD, and that it preferentially binds after mitotic phosphorylation ( Fig 1C) . Treatment of mitotic GBF1 with alkaline phosphatase abolished this binding, indicating that it is dependent upon phosphorylation. The alkaline phosphatase-sensitive molecular weight shift of mitotic versus interphase GBF1 was also seen in total cell extracts, confirming that GBF1 is phosphorylated in vivo ( Fig 1D; see also Fig 3C) .
GBF1 is phosphorylated by CDK1
To identify the kinase responsible for mitotic GBF1 phosphorylation we first prepared recombinant N-terminally GST-tagged full-length protein from insect cells. As shown in Fig 2A, GST-GBF1 was phosphorylated by mitotic cytosol. The amount of phosphorylation was comparable to that of GM130, one of the major Golgi phosphoproteins [12, 52] . As expected, and in contrast to GM130, GST-GBF1 was also phosphorylated by interphase cytosol, although to a lower level than mitotic cytosol (Fig 2A) . Many PBD binding proteins rely on phosphorylation by proline-directed kinases, most notably CDK1 in early mitosis, to generate the PBD recognition site [50] . We therefore tested whether GST-GBF1 phosphorylation was sensitive to the CDK1 inhibitors roscovitine and CGP74154A. Mitotic phosphorylation of GST-GBF1 was sensitive to both inhibitors, with a similar level of inhibition to that seen with the model CDK1 substrate histone III-S ( Fig 2B) . To examine this further, we used another measure of GBF1 phosphorylation, namely its shift in mobility upon SDS-PAGE. In vitro translated GBF1 was incubated with interphase or mitotic cytosol in the absence or presence of various kinase inhibitors. The mobility shift of GBF1, and hence its phosphorylation, was prevented by Roscovitine and CGP7415A, but not by the MEK1 inhibitor U0126 ( Fig 2C) . This is consistent with phosphorylation by CDK1 but not MEK1. To determine whether CDK1 phosphorylates GBF1 in vivo, mitotically arrested HeLa cells were treated with the CDK inhibitors CGP7415A and Purvalanol A and phosphorylation monitored by mobility shift. Both CDK inhibitors reduced the mobility shift of GBF1 in mitotic cells, indicating inhibition of phosphorylation, while U0126 had no effect ( Fig 2D) . The inhibitor effects were similar to those upon the known CDK1 substrate GM130 [12] , consistent with CDK1 phosphorylating GBF1 in vivo ( Fig 2D) . To confirm that CDK1 can directly phosphorylate GBF1, GST-GBF1 was incubated with purified Fig 2E, GST-GBF1 was phosphorylated by CDK1-cyclin B to a comparable level to that seen with mitotic cytosol. We conclude from these experiments that GBF1 is a substrate for the mitotic kinase CDK1.
Dissociation of GBF1 from Golgi membranes in mitosis
We next wanted to address the significance of GBF1 phosphorylation. We noticed that the amount of membrane associated GBF1 was reduced following incubation with mitotic cytosol (Figs 1A and B ), suggesting that phosphorylation may promote membrane dissociation. We investigated this in more detail by performing a time-course experiment. GBF1 rapidly dissociated from Golgi membranes incubated with mitotic cytosol, but not from those incubated with interphase cytosol ( Fig 3A) . The kinetics of dissociation were similar to those of p115, a golgin that is released from membranes upon CDK1-mediated phosphorylation of GM130 [18, 53] . Release of GBF1 was blocked by the general kinase inhibitor staurosporine or incubation with alkaline phosphatase, indicating that it is phosphorylation-dependent ( Fig 3B) . Analysis of subcellular fractions prepared from interphase and mitotic HeLa cells confirmed that membrane dissociation also occurs in vivo ( To further examine membrane dissociation of GBF1 in vivo, NRK cells were synchronized using an aphidicolin block/release protocol and analysed at various mitotic stages by immunofluorescence microscopy. The amount of GBF1 localised to the Golgi apparatus appeared reduced in late prophase and prometaphase cells compared to neighbouring interphase cells ( Fig 4A, top) . There was however residual Golgi staining evident at these mitotic stages, albeit with reduced intensity compared to the membrane-associated Golgi markers golgin-84 and GM130 ( Fig 4A and Fig S1A) . In metaphase, when the Golgi is highly fragmented, GBF1 staining appears mostly diffuse in the cytoplasm (Fig 4A, bottom) . A diffuse haze is also seen with golgin-84, which likely reflects the conversion of Golgi cisternal rims into numerous dispersed vesicles [20, 24, 27, 54] . The Golgi matrix protein GM130 remains associated with Golgi remnants that are readily observed at the light microscope level in metaphase cells [52] . These fragments are largely devoid of GBF1 although a low level of residual staining persists in some cells ( Fig 4B) . GBF1 remains diffuse in anaphase, and is largely absent from GM130 positive Golgi clusters ( Fig 4B) . During telophase, when the Golgi undergoes reassembly and secretory membrane traffic resumes [55] , GBF1 is again abundant at the Golgi apparatus ( Fig  4C) . Similar results were seen in unsynchronized HeLa cells ( Fig S1B) .
The GBF1 C-terminus regulates its phosphorylation and membrane association GBF1 contains many potential CDK1 phosphorylation sites, several of which are clustered in its C-terminus. To determine whether these residues are mitotically phosphorylated we generated a deletion mutant lacking the extreme C-terminal 59 residues and tested for phosphorylation by mitotic cytosol. As shown in Fig 5A, deletion of the C-terminal 59 residues abolished the molecular weight shift of in vitro translated GBF1 seen upon incubation with mitotic cytosol. Similarly, deletion of the C-terminus significantly reduced the amount of mitotic phosphorylation of GST-GBF1, but had little effect on the level of interphase phosphorylation ( Fig 5B) . Thus, the C-terminus of GBF1 is required for its phosphorylation in mitosis. We decided to use this information to confirm that it is phosphorylation of GBF1 itself rather than other proteins that regulates its membrane association. Wild-type and C-terminally truncated GBF1 were expressed at low levels in interphase or mitotic HeLa cells by retroviral transduction, and the amount of membrane-associated GBF1 assessed by subcellular fractionation. Expression of wild-type GBF1 or the C59 mutant has no effect upon mitotic entry, as revealed by FACS analysis (data not shown). Wild-type GBF1 dissociated from mitotic membranes as expected, whereas the C59 mutant remained bound during both interphase and mitosis ( Fig 5C) . This suggests that the Cterminal 59 residues of GBF1 are required for regulation of its membrane binding through mitotic phosphorylation. Unfortunately further attempts to map the C-terminal residues important for regulation of membrane binding were unsuccessful. Mutagenesis of all 8 potential phosphorylation sites to alanine failed to affect mitotic phosphorylation (data not shown), suggesting that the C-terminus is required for kinase docking, either directly as a binding site or through maintaining the correct 3-dimensional structure of the protein.
Membrane association of ARF and COPI in mitosis
GBF1 appears to be the only ARF GEF that is responsible for membrane recruitment of COPI [35, 36, 38, 39] . We therefore predicted that reduced levels of GBF1 at the Golgi in mitosis would affect membrane binding of both ARF and COPI. This was first analysed using the in vitro Golgi assay. To our surprise, both ARF and COPI remained membrane-associated for the duration of the incubation even though GBF1 was rapidly dissociated from the membrane ( Fig  6A) . We next investigated whether this was also true in vivo. Subcellular fractions were prepared from HeLa cells and analysed by Western blotting. As expected, both GBF1 and p115 were dissociated from the membrane in mitosis ( Fig 6B) . As seen in vitro, COPI remained membrane bound in mitotic cells (Fig 6B and C) . We could also show the membrane association of COPI in early mitosis by immunofluorescence microscopy (Fig 6D) . In contrast to what was observed in vitro, ARF appeared to partially dissociate from the membrane in mitotic cells (Fig 6B and C) . Fluorescence microscopy of transiently expressed ARF1-GFP also indicated a reduced level of membrane association in mitosis ( Fig S2) . These results suggest that levels of ARF-GTP may be reduced in mitosis, which would be consistent with a reduced amount of ARF GEF activity in mitotic cells. To test this possibility extracts were prepared from interphase and mitotic cells and binding to the ARF effector GGA3 used to monitor ARF-GTP levels. As shown in Fig 6E and F , there was a reduction in the levels of ARF-GTP in mitotic extracts. This result is consistent with a loss of GBF1 from the membrane resulting in reduced nucleotide exchange on ARF which in turn causes reduced membrane binding. In both interphase and mitotic conditions brefeldin-A, which inhibits several ARF GEFs [33] , causes a large decrease in ARF GTP levels, suggesting that there remains significant total ARF GEF activity in mitotic cells.
Since reduced GBF1 activity would be predicted to result in dissociation of COPI from the membrane, our results suggested that COPI may be uncoupled from GBF1 in mitosis. To investigate this possibility, mitotic cells were treated with BFA for 5 minutes and COPI localisation studied. As observed previously, BFA treatment prevented Golgi dispersion in prometaphase [56] , resulting in distinct golgin-84 positive foci in metaphase cells ( Fig 7A) . The Golgi fragments were devoid of COPI, indicating that COPI recruitment remains BFA sensitive in mitosis. A similar effect was observed with transiently expressed ARF-GFP, indicating that the low level of ARF recruitment in mitosis remains BFA sensitive ( Fig S2) . The simplest interpretation is that COPI still requires GBF1 for its recruitment to the membrane in mitosis, and that BFA inhibits GBF1 in mitotic cells. If this were the case we might expect BFA to lock GBF1 onto the membrane in an inactive complex with ARF-GDP, as is observed in interphase [32, 34, 35] . Note that the bulk of ARF is cytosolic under these conditions ( Fig 7A; and [32] . Analysis of GBF1 in BFA-treated cells confirmed that BFA did indeed lock GBF1 onto the membrane in mitosis, giving a clear labelling of Golgi fragments by microscopy ( Fig 7A) and a redistribution to the membrane fraction upon subcellular fractionation ( Fig 7B) . We observed similar effects upon COPI (and GBF1) distribution with the more specific GBF1 inhibitor Golgicide A [39] , confirming these effects are not due to inhibition of other ARF GEFs in mitotic cells (data not shown). These results suggest that even though GBF1 distribution shifts to the soluble pool in mitosis, it continues to cycle on and off Golgi membranes such that it can be trapped in an inactive complex with ARF-GDP on membranes upon BFA or Golgicide A treatment. This complex would contain phosphorylated GBF1, since the level of GBF1 phosphorylation in mitotic cells is unaffected by treatment with BFA or GCA (data not shown). Together our data suggest that despite its reduced membrane binding, GBF1 provides sufficient ARF exchange activity to allow continued recruitment of COPI onto Golgi membranes in mitotic cells. In line with this, fluorescence recovery after photobleaching (FRAP) analysis of GFP-tagged COPI indicates that its membrane recruitment occurs at the same rate in mitosis as it does in interphase, consistent with a similar mode of recruitment during both cell cycle stages (Fig S3) .
Discussion
In this study we have identified GBF1 as a novel mitotic phosphoprotein. Phosphorylation is quantitative; that is, the entire pool of cellular GBF1 is phosphorylated in mitotic cells. Phosphorylation causes membrane dissociation of GBF1, resulting in a redistribution to the cytoplasm. Since GBF1 is thought to catalyse nucleotide exchange on ARF at the membrane, this would be predicted to reduce cellular ARF-GTP levels, which is what we observed in our experiments. However, membrane-bound levels of COPI appeared unaffected, suggesting that low levels of GBF1 activity persist in mitosis that are sufficient to recruit COPI to the membrane. In line with this, the dynamics of COPI membrane association are similar in both interphase and mitotic cells. Thus the pool of ARF1 responsible for COPI recruitment appears unaffected by membrane dissociation of GBF1 in mitosis. This pool of ARF is likely important for driving the COPI mediated vesiculation of the Golgi as it undergoes mitotic disassembly [14, 57] . Interestingly, COPI subunits can undergo phosphorylation in mitosis [58, 59] , and consistent with this the COPI subunit -COP undergoes a molecular weight shift under mitotic conditions, although this could correspond to another post-translational modification such as ubiquitylation [57] . The significance of these modifications is so far unclear, but our results suggest they do not have a major effect on COPI membrane recruitment.
Two models have been proposed to explain the Golgi fragmentation that occurs in mitosis. These are the COPI budding model, in which the cisternae are converted into vesicles by continual COPI budding [13] , or the BFA-like fragmentation model, in which loss of ARF and COPI from the membrane cause extensive tubulation and eventually Golgi dispersion, which may be followed by fusion with the ER [21, 22] . The loss of GBF1 from the membrane would appear to support the latter model. However, as described above, we do not see a loss of COPI from the membrane, contrary to Altan-Bonnet et al, who used fluorescence imaging techniques to study COPI membrane association [21] . We did see a reduction in ARF binding to the membrane, but there remained a pool of membrane-associated GTP-bound ARF in mitotic cells. Thus our findings do not support a BFA-type Golgi dispersion in mitosis, and are more consistent with a COPI-mediated fragmentation mechanism, as described by others [14, 57] . If phosphorylation and membrane dissociation of GBF1 does not affect membrane-bound levels of COPI, what is its significance? ARF is responsible for the recruitment of numerous effectors to the Golgi membrane [60, 61] , including some proteins that appear to have non-Golgi roles in mitosis [21] . Thus, as originally suggested by Altan-Bonnet et al [21] , the regulation of ARF in mitosis, which we have shown occurs through GBF1 phosphorylation, may be important for mitotic events that are distinct from those occurring at the Golgi apparatus. A reduced pool of GBF1-catalyzed 
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active ARF at the Golgi would allow release of factors from the membrane and their recruitment to distal sites where they carry out their mitosis-specific functions, that in turn are required for cell cycle progression. It is also possible that reduced levels of ARF-GTP may influence Golgi events other than COPI-mediated vesicle budding.
We found that GBF1 is phosphorylated by CDK1-cyclin B. Inhibition of MEK1 failed to affect phosphorylation arguing against downstream MAP kinases as relevant GBF1 kinases. However, we cannot exclude a role for other kinases in GBF1 phosphorylation. We identified GBF1 as a Plk1 PBD binding partner, suggesting that GBF1 can bind to Plk1 in mitosis. Thus it is possible that Plk1 can phosphorylate GBF1, which may occur after initial priming phosphorylation by CDK1 on Plk1 PBD recognition sites. Alternatively, binding of Plk1 to GBF1 in mitosis may simply target the kinase to regions of the Golgi involved in COPI vesicle budding, at least at early stages of mitosis when the majority of GBF1 has yet to dissociate from the membrane. This would suggest that Plk1 can be recruited to the Golgi through binding to several Golgi proteins, including GRASP65 and rab1 [51] . The large number of Golgi phosphoproteins isolated in our Plk1 PBD binding experiments supports this possibility. This may ensure that relevant targets on distinct regions and functional domains of the Golgi are phosphorylated in an appropriate and timely manner.
Despite several attempts we were unable to identify the mitosis-specific phosphorylation sites in GBF1. Deletion of the C-terminal 59 residues of GBF1 abrogated mitotic phosphorylation, suggesting sites within this region are phosphorylated. However, mutation of all eight potential sites in this region failed to prevent GBF1 phosphorylation, suggesting that this region is required for recognition by CDK1 and possibly other kinases. Interestingly there are another six potential CDK1 sites immediately upstream of this region, some of which may correspond to the GBF1 phosphorylation sites, although it is equally possible that CDK1 sites in other parts of the protein are the ones that are phosphorylated. Using mass spectrometry we could identify several GBF1 phosphorylation sites, including Ser1298, Ser1318, Ser1320, Ser1335, and Thr1337, but all of these sites were phosphorylated to the same degree in both interphase and mitosis (data not shown). Thr1337 was previously shown to be phosphorylated by AMPK when cellular AMP levels are elevated, and to trigger Golgi disassembly under these conditions [62] . Our results suggest that Thr1337 is also phosphorylated constitutively in interphase cells, and that the steady-state levels of phosphorylation at this site do not disassemble the Golgi. Several large scale proteomics studies have identified additional GBF1 phosphorylation sites, of which only four (Ser314, Ser599, Tyr1316, Ser1773) appear to be mitosis-specific and conserved between mammals [58, 59, 63] . Of these, two are potential CDK1 sites (Ser314, Ser1773) although both lack the basic residue found in the CDK1 consensus site S/T-P-X-R/K. Additional studies will be required to identify the mitosis-specific phosphorylation sites in GBF1 that regulate membrane binding.
How might phosphorylation of GBF1 cause its release from the membrane? GBF1 binds to several proteins, including p115, rab1b and -COP [40] [41] [42] . It has been proposed that direct binding to rab1b is required for membrane recruitment of GBF1. However, despite numerous attempts we were unable to detect binding of GBF1 to rab1b, or indeed rab1a (unpublished observations). It therefore possible that rab1b acts indirectly to recruit GBF1 to the membrane, possibly through recruiting effectors to which GBF1 can bind. One such effector is p115, but previous work has shown that p115 is not required for targeting GBF1 to the membrane [41] suggesting an as yet unidentified rab1 effector is involved. Further investigation of how GBF1 binds to the membrane will be required to determine how it is recruited in interphase, and in turn how this is regulated by mitotic phosphorylation. and membrane fractions and subjected to Western blotting (WB) with the indicated antibodies. Note that 10x more membrane fraction was loaded relative to cytosol.
Figure 4. Localization of GBF1 during stages of mitosis
A, NRK cells were synchronized to enrich for mitotic cells and analyzed at the indicated mitotic stages by immunofluorescence microscopy with antibodies to GBF1 (green) and the cis-Golgi marker golgin-84 (red). B, Synchronized NRK cells were double-labelled with antibodies to GBF1 (green) and the cis-Golgi matrix protein GM130 (B) or golgin-84 (C) (red). DNA is in blue. Asterisks indicate interphase cells. Bar, 10 m. 
Figure 6. Membrane association of ARF and COPI in mitosis
A, Rat liver Golgi membranes were incubated with mitotic cytosol (M) for the indicated times at 30˚C, re-isolated and analysed by Western blotting (WB) with the indicated antibodies. B, Interphase (I) and mitotic (M) sHeLa cells were fractionated into cytosol and membrane fractions and subjected to Western blotting (WB) with the indicated antibodies. Note that 10x more membrane fraction was loaded relative to cytosol. C, Quantitation of membrane association of the indicated proteins. Bars indicate the amount of protein bound to mitotic membranes expressed as a percentage of that bound in interphase, normalized to the recovery of membranes as monitored by CASP. Data are expressed as the average + SD (n=4-7). D, NRK cells were synchronized and analysed by immunofluorescence microscopy with antibodies to COPI (green) and golgin-84 (red). DNA is in blue. The asterisk marks an interphase cell. Bar, 10 m. E, Extracts prepared from interphase (I) or mitotic (M) sHeLa cells were incubated with beads containing GST or GST-GGA3 and bound ARF detected by Western blotting (WB). The asterisk indicates a cross-reacting protein bound to the beads. F, Quantitation of ARF bound to GST-GGA3, indicating ARF-GTP levels. Results are expressed as the average + SD (n=4).
Figure 7. Effects of BFA on GBF1 and COPI in mitosis
A, NRK cells were synchronized to enrich for mitotic cells and incubated with 5 g/ml brefeldin-A (BFA) for 5 min at 37˚C prior to fixation and labelling with the indicated antibodies. Left panels are green, middle panels red in the merge. DNA is in blue. Asterisks indicate interphase cells. Bar, 10 m. B, Interphase (I) or nocodazole-arrested mitotic (M) sHeLa cells were treated with or without 5 g/ml BFA for 10 min at 37˚C, lysed and fractionated into post-nuclear cytosol and membrane fractions prior to analysis by Western blotting (WB) with the indicated antibodies. ZFPL1 is an integral Golgi membrane protein and used as a membrane marker. Note that 10x more membrane fraction was loaded relative to PNS and cytosol. A c c e p t e d M a n u s c r i p t Licenced copy. Copying is not permitted, except with prior permission and as allowed by law.
